These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2928636)

  • 1. Growth of Staphylococcus aureus and synthesis of toxic shock syndrome toxin 1 in different in vitro systems.
    Kirkland JJ; Ryan CA; Kohrman KA; Danneman PJ
    Rev Infect Dis; 1989; 11 Suppl 1():S188-95; discussion S195-6. PubMed ID: 2928636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production
    Nonfoux L; Chiaruzzi M; Badiou C; Baude J; Tristan A; Thioulouse J; Muller D; Prigent-Combaret C; Lina G
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29678918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Lee AC; Crass BA; Bergdoll MS
    J Clin Microbiol; 1987 Jan; 25(1):87-90. PubMed ID: 3793877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.
    Parsonnet J; Hansmann MA; Seymour JL; Delaney ML; Dubois AM; Modern PA; Jones MB; Wild JE; Onderdonk AB
    BMC Infect Dis; 2010 Aug; 10():249. PubMed ID: 20731864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay.
    Rosten PM; Bartlett KH; Chow AW
    J Clin Microbiol; 1987 Feb; 25(2):327-32. PubMed ID: 3818927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal tampon model for toxic shock syndrome.
    Melish ME; Murata S; Fukunaga C; Frogner K; McKissick C
    Rev Infect Dis; 1989; 11 Suppl 1():S238-46; discussion S246-7. PubMed ID: 2928642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of magnesium on in vitro production of toxic shock syndrome toxin 1.
    James JF; Chu MC; Lee L; Peck SA; McKissick C; Sullivan H; Frogner K; Melish M
    Rev Infect Dis; 1989; 11 Suppl 1():S157-66. PubMed ID: 2928632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A toroid model for in vitro investigations of toxic shock syndrome toxin-1 production.
    Flood JA; Tripp TJ; Davis CC; Hill DR; Schlievert PM
    J Microbiol Methods; 2004 May; 57(2):283-8. PubMed ID: 15063069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1) production and Lactobacillus species growth in a defined medium simulating vaginal secretions.
    Stingley RL; Liu H; Mullis LB; Elkins CA; Hart ME
    J Microbiol Methods; 2014 Nov; 106():57-66. PubMed ID: 25135489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of magnesium on the formation of toxic shock syndrome toxin 1 (TSST-1) by Staphylococcus aureus].
    Dickgiesser N; Wallach U
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Mar; 263(4):572-6. PubMed ID: 3111133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid requirements of Staphylococcus aureus strains from Germany and Austria that produce toxic shock syndrome toxin-1 (TSST-1).
    Dickgiesser N; Eppli P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 268(1):1-7. PubMed ID: 3394445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.
    Garbe PL; Arko RJ; Reingold AL; Graves LM; Hayes PS; Hightower AW; Chandler FW; Broome CV
    JAMA; 1985 May; 253(17):2538-42. PubMed ID: 3981783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of trace metals on the synthesis of toxic shock syndrome toxin 1.
    Reeves MW
    Rev Infect Dis; 1989; 11 Suppl 1():S145-49; discussion S149-50. PubMed ID: 2928630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
    Bonventre PF; Weckbach L; Harth G; Haidaris C
    Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the Today contraceptive sponge on growth and toxic shock syndrome toxin-1 production by Staphylococcus aureus.
    Remington KM; Buller RS; Kelly JR
    Obstet Gynecol; 1987 Apr; 69(4):563-9. PubMed ID: 3822297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of environmental conditions on production of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Wong AC; Bergdoll MS
    Infect Immun; 1990 Apr; 58(4):1026-9. PubMed ID: 2108084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of focal growth conditions on the pathogenesis of toxic shock syndrome.
    Todd JK; Todd BH; Franco-Buff A; Smith CM; Lawellin DW
    J Infect Dis; 1987 Apr; 155(4):673-81. PubMed ID: 3546518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental factors affecting toxic shock syndrome toxin-1 (TSST-1) synthesis.
    Sarafian SK; Morse SA
    J Med Microbiol; 1987 Aug; 24(1):75-81. PubMed ID: 3612745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.
    Kanclerski K; Söderquist B; Kjellgren M; Holmberg H; Möllby R
    J Med Microbiol; 1996 Mar; 44(3):171-7. PubMed ID: 8636933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.
    Schlievert PM
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):31-38. PubMed ID: 31853743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.